BrainNavigator: An online atlas to browse brain structures: Elsevier just released the official version of the BrainNavigator online virtual brain browser, an application developed in cooperation with the Allen Institute for Brain Science. Featuring a 3D interactive video interface, as well as traditional slices from a variety of animal brains, the software is designed for quick identification of neuroanatomical structures for scientists studying the organ.
Welcome to MassDevice's Neurological Hub, your resource for the latest news in neurology device news. Stay informed about the innovations and business news shaping the neurological industry.
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
Brain micro-electrodes create new possibilities: Neurosurgeons from the University of Utah have developed new tiny electrode arrays that do not penetrate the surface of the brain, potentially preventing many of the side effects common to modern high precision electrodes. Similar to electrocorticography arrays, the micro-ECoG devices may be small enough for permanent placement under the skull.
Boston Scientific Corp. plans to make the Emerald Isle a little greener, with a roughly $30 million investment in one of its research and development centers in Cork, Ireland, the Finfacts website reported.
It’s the second such investment for the Natick devices giant in as many months, following its planned $128 million spend on another R&D facility in Galway.
Aspect Medical Systems Inc. amended the terms of its credit agreement with Bank of America, reducing its revolving line from $5 million to $2 million and extending the due date for a year.
The Norwood-based brain-monitoring equipment maker said any funds borrowed from the credit line are due May 7, 2010, rather than May 8 of this year.
The study, conducted by researchers at the Barrow Neurological Institute in Phoenix (which also funded the study using materials supplied by OmniGuide), compared the BeamPath scalpel with a standard procedure called bipolar electrocautery, according to Yair Schindel, OmniGuide’s VP of clinical affairs and business development.
Philips Medizin Systeme GmbH will purchase and distribute the Norwood-based company’s BISx kits, BIS sensors and peripherals for at least three years. The contract also has two one-year automatic renewals written into it. Other terms of the deal were not disclosed.
The Waltham-based neurological testing equipment manufacturer posted sales of $6.8 million for the quarter, compared with $8.7 million for the same period last year. But 90 percent of those sales were derived from consumables, with medical equipment making up less than 10 percent.
Strong international sales helped Aspect Medical Systems Inc. boost revenues 4 percent and pushed the company into the black during the first quarter of 2009.
The Norwood-based brain-monitoring equipment maker posted revenues of $25.3 million for the three-month period ended March 31, compared to $24.4 million for the same period last year.
That pushed the company into the black. Aspect reported net income of $1.9 million, compared to a $235,000 loss during the first quarter of 2009.
Aspect Medical Systems Inc. cut a deal with a New York investment fund rather than face a protracted and messy board fight.
The Norwood-based brain-monitoring equipment maker said it will support the nomination of Jon Biro and Melvin Keating, both of First Biomed LLC, to its board of directors for three-year terms starting in June. Keating will also be given a seat on the compensation committee and Biro will be appointed to the auditing committee.
Officials at Aspect Medical Systems Inc. are delaying the company’s annual meeting to prepare for a possible proxy fight against two of its largest stockholders.
Officials at the Norwood-based brain-monitoring equipment maker said they needed “sufficient time to consider the potential director candidates, and provide shareholders with adequate time to consider the Board’s nominees,” according to a filing with the federal Securities and Exchange Commission.